Signifier Medical Technologies, based in Boston, announces the publication of a study titled “Cost-Effectiveness of Neuromuscular Electrical Stimulation for the Treatment of Mild Obstructive Sleep Apnea” in The International Journal of Technology Assessment in Health Care. Led by Drs. Shan…
Thermo Fisher Scientific Inc., a global leader in scientific solutions, has introduced a new CorEvitas syndicated clinical registry focusing on generalized pustular psoriasis (GPP). The registry, now open for enrollment, fills a crucial gap in real-world evidence (RWE) concerning clinical…
“Findhelp, a leading closed-loop referral management software company, is pleased to announce a partnership with Foothold Technology, a top provider of Human Services Electronic Health Record (EHR) and Care Coordination software. This collaboration aims to integrate mental and behavioral health…
LEO Pharma, a parent company of Timber Pharmaceuticals, Inc., presents initial findings from the ASCEND trial in a late-breaking session at the 2024 American Academy of Dermatology (AAD) Annual Meeting. The study provides a preliminary assessment of safety, efficacy, and…
Incyte (Nasdaq:INCY) disclosed findings from a Phase 2 trial examining povorcitinib (INCB54707), an oral JAK1 inhibitor’s effectiveness and safety among adult patients with prurigo nodularis (PN). These results were presented during a late-breaking oral session (Session: S050 – Late-Breaking Research:…
Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), a leading RNAi therapeutics company, has announced positive results from the Phase 2 KARDIA-2 trial of zilebesiran, an RNAi therapeutic designed to treat hypertension by targeting liver-expressed angiotensinogen (AGT). The trial met its primary endpoint,…
Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a global leader in insulin delivery and diabetes technology, has announced the pricing of $275.0 million aggregate principal amount of 1.50% Convertible Senior Notes due 2029 (the “notes”) in a private placement. This offering,…
LivaNova PLC (Nasdaq: LIVN), a prominent player in the medical technology sector, has announced the pricing of $300 million aggregate principal amount of 2.50% convertible senior notes due 2029 (referred to as the “notes”). These notes will be issued in…
Amidst projections of the smart home market reaching $345.6 billion by 2032 (Source: IMARC Group), the sector of home healthcare and air purification devices is rapidly growing. Fueled by the COVID-19 pandemic, these products now comprise 11% of the market.…
Aktana, Inc., a pioneer in intelligent customer engagement for the life sciences and medical sector, unveils “Aktana for MedTech,” offering AI-driven tools to enhance representative field execution, account coordination, and medical education programs. Aktana, Inc., a leader in intelligent customer…
GenSight Biologics (Euronext: SIGHT, ISIN: FR0013183985, PEA-PME eligible), a prominent biopharmaceutical company specializing in innovative gene therapies for retinal neurodegenerative diseases and central nervous system disorders, has disclosed recent prospective real-world data from early access programs (EAP) affirming the efficacy…
Haemonetics Corporation (NYSE: HAE), a leading global medical technology firm dedicated to enhancing patient outcomes, has revealed its definitive agreement to acquire Attune Medical, a Chicago-based private company renowned for producing the ensoETM® proactive esophageal cooling device. This device, the…